Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic

Non-pharmaceutical interventions implemented to mitigate COVID-19 transmission are likely to have impacted spread of other infectious diseases. Here, the authors investigate changes in the incidence of 31 notifiable infectious diseases using surveillance data from China.

Guardado en:

Detalles Bibliográficos
Autores principales:	Meng-Jie Geng, Hai-Yang Zhang, Lin-Jie Yu, Chen-Long Lv, Tao Wang, Tian-Le Che, Qiang Xu, Bao-Gui Jiang, Jin-Jin Chen, Simon I. Hay, Zhong-Jie Li, George F. Gao, Li-Ping Wang, Yang Yang, Li-Qun Fang, Wei Liu
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/289219934cee4318b892ea1e138b6447
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:289219934cee4318b892ea1e138b6447
record_format	dspace
spelling	oai:doaj.org-article:289219934cee4318b892ea1e138b64472021-11-28T12:31:31ZChanges in notifiable infectious disease incidence in China during the COVID-19 pandemic10.1038/s41467-021-27292-72041-1723https://doaj.org/article/289219934cee4318b892ea1e138b64472021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-27292-7https://doaj.org/toc/2041-1723Non-pharmaceutical interventions implemented to mitigate COVID-19 transmission are likely to have impacted spread of other infectious diseases. Here, the authors investigate changes in the incidence of 31 notifiable infectious diseases using surveillance data from China.Meng-Jie GengHai-Yang ZhangLin-Jie YuChen-Long LvTao WangTian-Le CheQiang XuBao-Gui JiangJin-Jin ChenSimon I. HayZhong-Jie LiGeorge F. GaoLi-Ping WangYang YangLi-Qun FangWei LiuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Meng-Jie Geng Hai-Yang Zhang Lin-Jie Yu Chen-Long Lv Tao Wang Tian-Le Che Qiang Xu Bao-Gui Jiang Jin-Jin Chen Simon I. Hay Zhong-Jie Li George F. Gao Li-Ping Wang Yang Yang Li-Qun Fang Wei Liu Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
description	Non-pharmaceutical interventions implemented to mitigate COVID-19 transmission are likely to have impacted spread of other infectious diseases. Here, the authors investigate changes in the incidence of 31 notifiable infectious diseases using surveillance data from China.
format	article
author	Meng-Jie Geng Hai-Yang Zhang Lin-Jie Yu Chen-Long Lv Tao Wang Tian-Le Che Qiang Xu Bao-Gui Jiang Jin-Jin Chen Simon I. Hay Zhong-Jie Li George F. Gao Li-Ping Wang Yang Yang Li-Qun Fang Wei Liu
author_facet	Meng-Jie Geng Hai-Yang Zhang Lin-Jie Yu Chen-Long Lv Tao Wang Tian-Le Che Qiang Xu Bao-Gui Jiang Jin-Jin Chen Simon I. Hay Zhong-Jie Li George F. Gao Li-Ping Wang Yang Yang Li-Qun Fang Wei Liu
author_sort	Meng-Jie Geng
title	Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
title_short	Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
title_full	Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
title_fullStr	Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
title_full_unstemmed	Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
title_sort	changes in notifiable infectious disease incidence in china during the covid-19 pandemic
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/289219934cee4318b892ea1e138b6447
work_keys_str_mv	AT mengjiegeng changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT haiyangzhang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT linjieyu changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT chenlonglv changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT taowang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT tianleche changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT qiangxu changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT baoguijiang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT jinjinchen changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT simonihay changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT zhongjieli changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT georgefgao changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT lipingwang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT yangyang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT liqunfang changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic AT weiliu changesinnotifiableinfectiousdiseaseincidenceinchinaduringthecovid19pandemic
_version_	1718407880582889472

Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic

Ejemplares similares